Nicotine E-Cigarettes are More Effective in Smoking Cessation

Industry Insight by 2FIRSTS.ai
Jan.09.2024
Nicotine E-Cigarettes are More Effective in Smoking Cessation
A new review by a public health researcher at UMass Amherst suggests that nicotine e-cigarettes are more effective for quitting smoking than traditional nicotine replacement therapy.

According to a report by metronews on January 9, a recent review conducted by a public health and health policy researcher at the University of Massachusetts Amherst suggests that nicotine e-cigarettes are more effective in helping people quit smoking compared to traditional nicotine replacement therapy.

 

A review conducted on studies published in the Cochrane Database of Systematic Reviews found that e-cigarettes, which allow users to inhale nicotine without smoking, are more effective in helping smokers quit compared to patches, gums, lozenges, or other traditional nicotine replacement therapies. The review also found strong evidence to support this view. While acknowledging that nicotine e-cigarettes are not without risks, the study concluded that they are significantly less harmful to health. Research in countries such as the United States, the United Kingdom, and Italy has shown that e-cigarettes containing nicotine pose a lower risk compared to traditional cigarettes.

 

A study has shown that out of every 100 people who use nicotine e-cigarettes to quit smoking, it is expected that 8-10 individuals will successfully quit. In comparison, among those who use traditional nicotine replacement therapies, 6 people are able to successfully quit, and out of those who attempt to quit without any assistance, 4 people are successful.

 

Despite controversy, the research authors emphasize the positive role of nicotine e-cigarettes in aiding smoking cessation. It is important to note that the study specifically highlights the potential negative impact of using e-cigarettes for non-smokers when discussing the possibility of improving health through nicotine e-cigarettes.

 

Despite the approval of various medications by the Food and Drug Administration (FDA) to aid adults in quitting smoking, nicotine e-cigarettes have yet to be included. FDA Commissioner Robert Califf stated in an update on the tobacco program earlier this year, "While some nicotine e-cigarettes may assist adult smokers in completely quitting or significantly reducing their use of more harmful combustible cigarettes, public health regulations must balance this potential with the known, considerably high risks of these products' appeal, adoption, and addictiveness among young people.

 

This study provides strong evidence for public health policies and smoking cessation strategies, offering better tools for smokers to quit. While the effects of e-cigarettes on health are complex, quitting smoking through the use of e-cigarettes may be a pathway towards improving health for smokers.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

VEEV Arrives in South Korea, Completing PMI’s IQOS-ZYN-VEEV Portfolio
VEEV Arrives in South Korea, Completing PMI’s IQOS-ZYN-VEEV Portfolio
Philip Morris Korea has officially launched its VEEV e-vapor brand in South Korea, introducing both the VEEV inPRIME device and VEEBI inPRIME pods. The launch further expands PMI’s smoke-free portfolio in Korea, alongside its IQOS heated tobacco products and ZYN nicotine pouches.
Jun.16
Why Many E-Liquids Today Are "Not Bad, but Not Memorable" – Mylor’s Approach to Experience Design
Why Many E-Liquids Today Are "Not Bad, but Not Memorable" – Mylor’s Approach to Experience Design
From May 8 to 10, 2026, Mylor (Booth E70) will exhibit at The Vaper Expo UK, where it will showcase its systematic experience design solutions for e-liquids. At present, the e-liquid market commonly faces a challenge: many products have “no obvious shortcomings, but lack memorable features.” In response, Mylor has proposed refined solutions across multiple dimensions, including device-adaptive sweetness, progressive cooling sensation, fruit-oriented sourness, and segmented nicotine experience.
May.08
U.S. Senator Durbin Criticizes FDA’s First Flavored Vape Authorization, Says Trump Administration Conceded to Big Tobacco
U.S. Senator Durbin Criticizes FDA’s First Flavored Vape Authorization, Says Trump Administration Conceded to Big Tobacco
U.S. Senator Dick Durbin on May 13 criticized the Trump Administration’s Food and Drug Administration for approving the sale and marketing of fruit-flavored e-cigarettes for the first time, while also allowing some illegal vaping products to remain on the market. He also linked the regulatory shift to the departure of FDA Commissioner Marty Makary, saying White House pressure on regulators to approve tobacco product applications could create serious public-health consequences.
Regulations
May.15
South Korea Rejects 16 Trillion Won Tax-Evasion Claim Over Chinese Synthetic Nicotine
South Korea Rejects 16 Trillion Won Tax-Evasion Claim Over Chinese Synthetic Nicotine
The South Korean government rejected allegations that Chinese synthetic-nicotine e-liquids were linked to about 16 trillion won in tobacco tax evasion, saying China does not ban synthetic nicotine exports and the estimate is difficult to verify, while acknowledging that pre-law synthetic-nicotine inventory is effectively difficult to tax.
Market
Jun.25
Product | KT&G Expands lil AIBLE 3.0 Sales to Seoul Convenience Stores, Launches Two New AIIM Variants
Product | KT&G Expands lil AIBLE 3.0 Sales to Seoul Convenience Stores, Launches Two New AIIM Variants
According to South Korean media reports, KT&G has expanded sales of its heated tobacco device lil AIBLE 3.0 to convenience stores across Seoul starting May 13. The convenience-store version is offered in the exclusive OUD GRAY color. On the same day, KT&G also launched two new dedicated consumables for the lil AIBLE platform—AIIM REMIX and AIIM ICESPOT—at convenience stores nationwide, each priced at KRW 4,800.
Market
Jun.01
 BAT London Shares Gain 13.99% as FDA Vape Decision Draws Market Attention
BAT London Shares Gain 13.99% as FDA Vape Decision Draws Market Attention
British American Tobacco’s London-listed shares rose 13.99% last week, as investors focused on the U.S. Food and Drug Administration’s recent authorization of flavored Glas e-cigarette products, the dismissal of a U.S. sanctions-related criminal case against BAT, and the company’s previously announced share buyback plan and newer nicotine business performance.
BAT
May.18